Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VALEANT PHARMACEUTICALS INTL INC T.VRX

Healthcare Drug Manufacturers - Specialty & Generic
"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

TSX:VRX - Post Discussion

VALEANT PHARMACEUTICALS INTL INC > NY Times Op Ed
View:
Post by MBertolli on Oct 27, 2015 1:11pm

NY Times Op Ed

https://www.nytimes.com/2015/10/27/opinion/is-valeant-pharmaceuticals-the-next-enron.html?smid=tw-nytimes&smtyp=cur&_r=0
Comment by adamchess on Oct 27, 2015 2:15pm
Pretty much everyone has cleared Valeant of any possible fraud possibilities. Get with the program dude.
Comment by RE38 on Oct 27, 2015 2:30pm
Umm...we'll see what the insurance companies say about that... I bet they're just ecstatic that they've been paying top dollar for prescriptions that a patient no longer needs. Even if this is an industry problem that Valeant is not singled out...that doesn't make VRX a good stock to buy, that just means the other large unscrupolous pharmas are a strong sell.
Comment by adamchess on Oct 28, 2015 5:56pm
I understand it was not Valeant making these sales and they will do just fine without them. Regards
VALEANT PHARMACEUTICALS INTL INC